Concordance of Lumipulse cerebrospinal fluid t-tau/Aβ42 ratio with amyloid PET status
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Concordance of Lumipulse cerebrospinal fluid t-tau/Aβ42 ratio with amyloid PET status
Authors
Keywords
-
Journal
Alzheimers & Dementia
Volume 16, Issue 1, Pages 144-152
Publisher
Wiley
Online
2020-01-16
DOI
10.1002/alz.12000
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Assessment of Racial Disparities in Biomarkers for Alzheimer Disease
- (2019) John C. Morris et al. JAMA Neurology
- The Alzheimer’s Disease Clinical Spectrum
- (2019) Alireza Atri MEDICAL CLINICS OF NORTH AMERICA
- The neuropathological diagnosis of Alzheimer’s disease
- (2019) Michael A. DeTure et al. Molecular Neurodegeneration
- Cerebrospinal fluid biomarkers measured by Elecsys assays compared to amyloid imaging
- (2018) Suzanne E. Schindler et al. Alzheimers & Dementia
- The impact of preanalytical variables on measuring cerebrospinal fluid biomarkers for Alzheimer's disease diagnosis: A review
- (2018) Oskar Hansson et al. Alzheimers & Dementia
- CSF biomarkers of Alzheimer's disease concord with amyloid-β PET and predict clinical progression: A study of fully automated immunoassays in BioFINDER and ADNI cohorts
- (2018) Oskar Hansson et al. Alzheimers & Dementia
- NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease
- (2018) Clifford R. Jack et al. Alzheimers & Dementia
- Biomarkers for Alzheimer's disease: current status and prospects for the future
- (2018) K. Blennow et al. JOURNAL OF INTERNAL MEDICINE
- Appropriate use criteria for lumbar puncture and cerebrospinal fluid testing in the diagnosis of Alzheimer's disease
- (2018) Leslie M. Shaw et al. Alzheimers & Dementia
- Concordance Between Cerebrospinal Fluid Biomarkers with Alzheimer’s Disease Pathology Between Three Independent Assay Platforms
- (2017) James D. Doecke et al. JOURNAL OF ALZHEIMERS DISEASE
- Clinical validity of cerebrospinal fluid Aβ42, tau, and phospho-tau as biomarkers for Alzheimer's disease in the context of a structured 5-phase development framework
- (2017) Niklas Mattsson et al. NEUROBIOLOGY OF AGING
- A phase III randomized trial of gantenerumab in prodromal Alzheimer’s disease
- (2017) Susanne Ostrowitzki et al. Alzheimers Research & Therapy
- Regional correlations between [ 11 C]PIB PET and post-mortem burden of amyloid-beta pathology in a diverse neuropathological cohort
- (2017) Sang Won Seo et al. NeuroImage-Clinical
- Imaging and cerebrospinal fluid biomarkers in early preclinical alzheimer disease
- (2016) Andrei G. Vlassenko et al. ANNALS OF NEUROLOGY
- Cerebrospinal fluid analysis detects cerebral amyloid-β accumulation earlier than positron emission tomography
- (2016) Sebastian Palmqvist et al. BRAIN
- Cerebrospinal Fluid Aβ42/40 Corresponds Better than Aβ42 to Amyloid PET in Alzheimer’s Disease
- (2016) Piotr Lewczuk et al. JOURNAL OF ALZHEIMERS DISEASE
- Amyloid Imaging: Poised for Integration into Medical Practice
- (2016) Keshav Anand et al. Neurotherapeutics
- Underrepresentation of African-Americans in Alzheimer's Trials: A Call for Affirmative Action
- (2016) Jaewook Shin et al. Frontiers in Aging Neuroscience
- Partial volume correction in quantitative amyloid imaging
- (2015) Yi Su et al. NEUROIMAGE
- Amyloid biomarkers in Alzheimer's disease
- (2015) Kaj Blennow et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Targeting Prodromal Alzheimer Disease With Avagacestat
- (2015) Vladimir Coric et al. JAMA Neurology
- The A4 Study: Stopping AD Before Symptoms Begin?
- (2014) R. A. Sperling et al. Science Translational Medicine
- Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers
- (2013) Clifford R Jack et al. LANCET NEUROLOGY
- Quantitative Analysis of PiB-PET with FreeSurfer ROIs
- (2013) Yi Su et al. PLoS One
- Cerebrospinal Fluid Levels ofβ-Amyloid 1-42, but Not of Tau, Are Fully Changed Already 5 to 10 Years Before the Onset of Alzheimer Dementia
- (2012) Peder Buchhave ARCHIVES OF GENERAL PSYCHIATRY
- Accuracy of the Clinical Diagnosis of Alzheimer Disease at National Institute on Aging Alzheimer Disease Centers, 2005–2010
- (2012) Thomas G. Beach et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: a prospective cohort study
- (2012) Christopher M Clark et al. LANCET NEUROLOGY
- Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
- (2012) Randall J. Bateman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Comparison of Analytical Platforms for Cerebrospinal Fluid Measures of β-Amyloid 1-42, Total tau, and P-tau181 for Identifying Alzheimer Disease Amyloid Plaque Pathology
- (2011) Anne M. Fagan ARCHIVES OF NEUROLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started